title: [Semiological profile of gout in patients with AA, AS and AC hemoglobins].
abstract: OBJECTIVE
  To search a possible difference in gout and in the risk factors for gout expression according to the of hemoglobin in patients seen at the lomé teaching hospital rheumatology clinic (Togo).
  
  
  METHODS
  Medical records of patients seen during 17 years were studied. The patients affected by the gout and answering New York criteria have been included. All patients object of the comparison, benefitted from a hemoglobin electrophoresis and the search of possible risk factors for gout.
  
  
  RESULTS
  Among the 14902 patients seen over a 17 year period, 214 had gout (210 males, 4 famales). These 214 patients were carriers of an AA hemoglobin (147 cases), of an AS hemoglobin (41 cases), or of an AC hemoglobin (26 cases). The alcoholism, the obesity, and the arterial hypertension were the main risk factors associated with gout in 207 patients (97%). Semiological and risk factors comparison according to the type of hemoglobin didn't show statistically significant difference.
  
  
  CONCLUSIONS
  it results from this study that the AS hemoglobin and AC hemoglobin don't exercise any influence on the gout semiological expression. Thus, the presence of one of these hemoglobins in gout patient must exercise no influence in the diagnostic gait and in the etiological investigation.
authors.affiliation: Service de rhumatologie, CHU-Tokoin de Lomé, Togo.
authors.forename: Owonayo
authors.initials: O
authors.lastname: Oniankitan
authors.forename: Eyram
authors.initials: E
authors.lastname: Fianyo
authors.forename: Prénam
authors.initials: P
authors.lastname: Houzou
authors.forename: Komi C
authors.initials: KC
authors.lastname: Tagbor
authors.forename: Moustafa
authors.initials: M
authors.lastname: Mijiyawa
mesh_terms: D000328:Adult; D000368:Aged; D000437:Alcoholism / Q000150:complications; D000755:Anemia, Sickle Cell / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology; D015415:Biomarkers / Q000097:blood; D005260:Female; D006073:Gout / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology; D006441:Hemoglobin A / Q000378:metabolism*; D006451:Hemoglobin, Sickle / Q000378:metabolism*; D006455:Hemoglobins, Abnormal / Q000378:metabolism*; D006801:Humans; D006973:Hypertension / Q000150:complications; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D012189:Retrospective Studies; D012307:Risk Factors; D014037:Togo / Q000453:epidemiology
chemical_list: D015415:Biomarkers; D006451:Hemoglobin, Sickle; D006455:Hemoglobins, Abnormal; C028672:hemoglobin AA; C076696:hemoglobin AC; C028671:hemoglobin AS; D006441:Hemoglobin A